Innospec Overview
Latest ROE for Innospec: 8.99% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow8.99%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for IOSP is 8.99%. That is below the Consumer Discretionary sector average of 22.95%. Investors often review this figure alongside Innospec's historical trend and sector peers before judging valuation or financial health.
Against Consumer Discretionary companies, IOSP currently prints 8.99% for ROE, while the sector average sits near 22.95%. That is roughly 60.8% below the sector mean. Large gaps often invite a closer look at Innospec's growth, margins, and balance sheet.
Return on Equity shows how effectively Innospec converts resources into returns. At 8.99%, IOSP may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting IOSP's ROE (8.99%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Innospec's ROE against similar Consumer Discretionary names. You can also browse sector and industry screens on Stockcircle for a broader set of Consumer Discretionary companies and their key multiples and fundamentals.
